Tag Archives: Cardiovascular disease
By Ben Comer | Published: May 7, 2012
The news that Roche scrapped development on its CETP inhibitor dalcetrapib, a drug designed to raise HDL cholesterol in the blood, likely presages the shuttering of Lilly’s development program for its CETP inhibitor, evacetrapib, industry experts and analysts say.
By Sarah Houlton | Published: July 22, 2009
Image via Wikipedia Statins should be given to people with high blood pressure or diabetes, even if they donâ€™t have heart disease, according to a study published in the British Medical Journal. While several studies have shown that statins benefit those with cardiovascular disease, this is the first large study which looked at statins as primary [...]